The Washington Post reports:
A coronavirus vaccine being developed by the Chinese pharmaceutical company SinoVac will be ready for worldwide distribution by early next year, its CEO said Thursday.
The vaccine, dubbed CoronaVac, is one of four in China that is still undergoing a third and final round of testing, a global standard necessary before it can be widely distributed. But if SinoVac’s vaccine makes it through Phase 3 of clinical trials, CEO Yin Weidong said he will apply to the U.S. Food and Drug Administration to sell it in the United States.
“At the very beginning, our strategy was designed for China and for Wuhan. Soon after that in June and July, we adjusted our strategy,” he said Thursday, according to the Associated Press. “Our goal is to provide the vaccine to the world.”